Home/ Stocks/ VIVS

VivoSim Labs, Inc. Common Stock

VIVS XNAS

$0.14 +0.00 (+2.47%) ▲ 15-min delayed

Open

$0.14

High

$0.14

Low

$0.14

Volume

167.5K

Market Cap

$1.90M

About VivoSim Labs, Inc. Common Stock

VivoSim Labs Inc is a pharmaceutical and biotechnology services company focused on testing drugs and drug candidates in three-dimensional human tissue models of the liver and intestine. The Company provides liver and intestinal toxicology insights using its new approach methodologies and models and offers liver toxicology predictive screening and research services, as well as services to predict and study the intestinal side effect profiles of therapeutic candidates at all stages of drug development. Its 3D human tissue platform includes expertise in 3D organoids, such as spheroids, and proprietary cell culture techniques.

Sector: BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES) Employees: 11 Website →

Related Market News

No specific coverage for VIVS yet. Check out our latest market news or earnings calendar.

Get VIVS Alerts

Stay ahead with breaking news, price alerts, and expert analysis on VivoSim Labs, Inc. Common Stock.

Disclaimer: This page is for informational purposes only. Stock data is delayed by at least 15 minutes. Always conduct your own research and consult with a qualified financial advisor before making investment decisions.